5IS5

Discovery and Pharmacological Characterization of Novel Quinazoline-based PI3K delta-selective Inhibitors

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2016-08-10	Initial release
1.1	2016-09-14		Database references
1.2	2017-01-18		Data collection
1.3	2019-04-24		Data collection, Source and taxonomy	entity_src_gen
1.4	2024-01-10		Data collection, Database references, Refinement description	chem_comp_atom, chem_comp_bond, database_2, pdbx_initial_refinement_model	Download

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.